The board of directors (the "Board") of WuXi AppTec Co., Ltd. announced the promotion of Ms. Shi Ming (‘Ms. Shi’), the senior vice president in finance of the Company as the chief financial officer of the Company with effect from January 1, 2022. Mr. Ellis Bih-Hsin Chu ("Mr. Chu") will act as the co-chief financial officer of the Company and the head of the mergers and acquisitions division with effect from January 1, 2022, with a focus on leading the Company's strategic mergers and acquisitions matters as well as the financial work in relation to the advanced therapies business unit ("WuXi ATU"), cell and gene therapy CTDMO platform. Ms. Shi's term of office as the chief financial officer shall commence on January 1, 2022 and end on the day of the annual general meeting of the Company to be convened in 2023.